Anti-AXL biologic increases tumor sensitivity to radiation and check-point inhibitors
Nature Communications publication describes mechanism by which AXL over-expression results in tumor unresponsiveness to radiation therapy and check-point inhibitors Inhibiting AXL elicits anti-tumor i..